Danske Bank downgraded Zealand Pharma to Sell from Buy with a DKK 600 price target. The analyst sees an unfavorable risk/reward following the post-data share rally.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZLDPF:
